467 articles across injectables, lasers, body contouring, skin therapeutics, and provider safety.
A comprehensive global regulatory and corporate analysis of Lumenis. We explore the $1.07B Boston Scientific acquisition split, global registry profiles, recall history,…
A clinical guide to breast implant removal surgery — comparing en bloc, total, and partial capsulectomy, the 2024 consensus on breast implant illness, recovery, and cost.
How the European Union Medical Device Regulation regulates aesthetic lasers, fillers, and implants, the 2026 EUDAMED mandatory deadlines, and how a CE mark compares to…
How the federal Sunshine Act and California AB 1278 expose manufacturer payments to dermatologists and plastic surgeons, how patients look up doctors, and what practices…
Are skin boosters FDA-approved? We analyze the US regulatory status of Skinvive, Profhilo, NCTF, Restylane Skinbooster, and how the FDA detains unapproved imports.
BTL Aesthetics is the force behind Emsculpt Neo, Emface, and Emsella. We analyze their complete FDA 510(k) clearances, indications, safety record, and the regulatory…
Venus Concept's aesthetic footprint spans Venus Legacy, Viva, and Bliss. We examine their complete FDA 510(k) approvals, safety record, and the major 2026 corporate…
A regulatory and clinical dossier profiling Galderma's aesthetic portfolio, its 250 FDA PMA supplements under Q-Med AB, Dysport BLA history, and MAUDE/FAERS safety…
A regulatory and clinical profile analyzing Prollenium's Revanesse filler line, its single FDA PMA P160042 architecture, Thixofix cross-linking, and MAUDE safety data.
A regulatory and clinical profile analyzing Teoxane's RHA Collection, its single FDA PMA P170002 architecture, Preserved Network Technology, and post-market safety data.